The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holmström, T. H.
Right arrow Articles by Eriksson, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holmström, T. H.
Right arrow Articles by Eriksson, J. E.
The Journal of Immunology, 1998, 160: 2626-2636.
Copyright © 1998 by The American Association of Immunologists

Suppression of Fas/APO-1-Mediated Apoptosis by Mitogen-Activated Kinase Signaling1

Tim H. Holmström*,{dagger}, Sek C. Chow§, Iina Elo*,{dagger}, Eleanor T. Coffey{ddagger}, Sten Orrenius, Lea Sistonen* and John E. Eriksson2,*

* Turku Center for Biotechnology, University of Turku and Åbo Akademi University, and Departments of {dagger} Biology and {ddagger} Biochemistry and Pharmacy, Åbo Akademi University, BioCity, Turku, Finland; § Center for Mechanisms of Human Toxicity, University of Leicester, Leicester, United Kingdom; and Institute of Environmental Medicine, Division of Toxicology, Karolinska Institute, Stockholm, Sweden

Jurkat T cells undergo rapid apoptosis upon stimulation of the Fas/APO-1 (CD95) receptor. We examined the role of the mitogen-activated protein kinase (MAPK) cascade as a negative regulator of Fas-mediated apoptosis. To this end, we used both physiologic and artificial activators of MAPK, all of which activate MAPK by distinct routes. MAPK activity could be efficiently elevated by two T cell mitogens, the lectin PHA and an agonistic Ab to the T cell receptor complex as well as by the type 1 and 2A phosphatase inhibitor, calyculin A, and the protein kinase C-activating phorbol ester, tetradecanoyl phorbol acetate. All these treatments were effective in preventing the characteristic early and late features of Fas-mediated apoptosis, including activation of caspases. Our results indicate that the elevated MAPK activities intervene upstream of caspase activation. The degree of MAPK activation by the different stimuli used in our study corresponds well to their potency to inhibit apoptosis, indicating that MAPK activation serves as an efficient modulator of Fas-mediated apoptosis. The role of MAPK in modulation of Fas-mediated apoptosis was further corroborated by transient transfection with constitutively active MAPK kinase, resulting in complete inhibition of the Fas response, whereas transfection with a dominant negative form of MAPK kinase had no effect. Furthermore, the apoptosis inhibitory effect of the MAPK activators could be abolished by the specific MAPK kinase inhibitor PD 098059. Modulation of Fas responses by MAPK signaling may determine the persistence of an immune response and may explain the insensitivity of recently activated T cells to Fas receptor stimulation.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
J. W. Peacock, J. Palmer, D. Fink, S. Ip, E. M. Pietras, A. L.-F. Mui, S. W. Chung, M. E. Gleave, M. E. Cox, R. Parsons, et al.
PTEN Loss Promotes Mitochondrially Dependent Type II Fas-Induced Apoptosis via PEA-15
Mol. Cell. Biol., March 1, 2009; 29(5): 1222 - 1234.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Engedal, P. Auberger, and H. K. Blomhoff
Retinoic acid regulates Fas-induced apoptosis in Jurkat T cells: reversal of mitogen-mediated repression of Fas DISC assembly
J. Leukoc. Biol., March 1, 2009; 85(3): 469 - 480.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Ruffell and P. Johnson
Hyaluronan Induces Cell Death in Activated T Cells through CD44
J. Immunol., November 15, 2008; 181(10): 7044 - 7054.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Li, X. Cai, X. Fan, B. Moquin, C. Stoicov, and J. Houghton
Fas Ag-FasL coupling leads to ERK1/2-mediated proliferation of gastric mucosal cells
Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G263 - G275.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. S. Byun, K. A. Park, M. Won, K.-J. Yang, S. Shin, L. Piao, J. Y. Kwak, Z.-W. Lee, J. Park, J. H. Seok, et al.
Phorbol 12-Myristate 13-Acetate Protects against Tumor Necrosis Factor (TNF)-Induced Necrotic Cell Death by Modulating the Recruitment of TNF Receptor 1-Associated Death Domain and Receptor-Interacting Protein into the TNF Receptor 1 Signaling Complex: Implication for the Regulatory Role of Protein Kinase C
Mol. Pharmacol., September 1, 2006; 70(3): 1099 - 1108.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
Y. Kang, S.-K. Kang, Y.-C. Lee, H.-J. Choi, Y.-S. Lee, S.-Y. Cho, Y.-S. Kim, J.-H. Ko, and C.-H. Kim
Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-{kappa}B in regulated expression
Glycobiology, May 1, 2006; 16(5): 375 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Nekrasova, C. Shive, Y. Gao, K. Kawamura, R. Guardia, G. Landreth, and T. G. Forsthuber
ERK1-Deficient Mice Show Normal T Cell Effector Function and Are Highly Susceptible to Experimental Autoimmune Encephalomyelitis
J. Immunol., August 15, 2005; 175(4): 2374 - 2380.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Gendron, J. Couture, and F. Aoudjit
Integrin {alpha}2{beta}1 Inhibits Fas-mediated Apoptosis in T Lymphocytes by Protein Phosphatase 2A-dependent Activation of the MAPK/ERK Pathway
J. Biol. Chem., December 5, 2003; 278(49): 48633 - 48643.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Engedal and H. K. Blomhoff
Combined Action of ERK and NFkappa B Mediates the Protective Effect of Phorbol Ester on Fas-induced Apoptosis in Jurkat Cells
J. Biol. Chem., March 21, 2003; 278(13): 10934 - 10941.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. Hietakangas, M. Poukkula, K. M. Heiskanen, J. T. Karvinen, L. Sistonen, and J. E. Eriksson
Erythroid Differentiation Sensitizes K562 Leukemia Cells to TRAIL-Induced Apoptosis by Downregulation of c-FLIP
Mol. Cell. Biol., February 15, 2003; 23(4): 1278 - 1291.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Gouaze, N. Andrieu-Abadie, O. Cuvillier, S. Malagarie-Cazenave, M.-F. Frisach, M.-E. Mirault, and T. Levade
Glutathione Peroxidase-1 Protects from CD95-induced Apoptosis
J. Biol. Chem., November 1, 2002; 277(45): 42867 - 42874.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. S. Soderstrom, M. Poukkula, T. H. Holmstrom, K. M. Heiskanen, and J. E. Eriksson
Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling in Activated T Cells Abrogates TRAIL-Induced Apoptosis Upstream of the Mitochondrial Amplification Loop and Caspase-8
J. Immunol., September 15, 2002; 169(6): 2851 - 2860.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. W. Meng, M. P. Heldebrant, and S. H. Kaufmann
Phorbol 12-myristate 13-Acetate Inhibits Death Receptor-mediated Apoptosis in Jurkat Cells by Disrupting Recruitment of Fas-associated Polypeptide with Death Domain
J. Biol. Chem., January 25, 2002; 277(5): 3776 - 3783.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-H. Ahn, S.-M. Park, H.-S. Cho, M.-S. Lee, J.-B. Yoon, J. Vilcek, and T. H. Lee
Non-apoptotic Signaling Pathways Activated by Soluble Fas Ligand in Serum-starved Human Fibroblasts. MITOGEN-ACTIVATED PROTEIN KINASES AND NF-kappa B-DEPENDENT GENE EXPRESSION
J. Biol. Chem., December 7, 2001; 276(50): 47100 - 47106.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. McFall, A. Ulku, Q. T. Lambert, A. Kusa, K. Rogers-Graham, and C. J. Der
Oncogenic Ras Blocks Anoikis by Activation of a Novel Effector Pathway Independent of Phosphatidylinositol 3-Kinase
Mol. Cell. Biol., August 15, 2001; 21(16): 5488 - 5499.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
M. Carloni, R. Meschini, L. Ovidi, and F. Palitti
PHA-induced cell proliferation rescues human peripheral blood lymphocytes from X-ray-induced apoptosis
Mutagenesis, March 1, 2001; 16(2): 115 - 120.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Willems, Z. Amraoui, N. Vanderheyde, V. Verhasselt, E. Aksoy, C. Scaffidi, M. E. Peter, P. H. Krammer, and M. Goldman
Expression of c-FLIPL and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide
Blood, June 1, 2000; 95(11): 3478 - 3482.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Bertolotto, J.-E. Ricci, F. Luciano, B. Mari, J.-C. Chambard, and P. Auberger
Cleavage of the Serum Response Factor during Death Receptor-induced Apoptosis Results in an Inhibition of the c-FOS Promoter Transcriptional Activity
J. Biol. Chem., April 21, 2000; 275(17): 12941 - 12947.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Burow, C. B. Weldon, B. M. Collins-Burow, N. Ramsey, A. McKee, A. Klippel, J. A. McLachlan, S. Clejan, and B. S. Beckman
Cross-talk between Phosphatidylinositol 3-Kinase and Sphingomyelinase Pathways as a Mechanism for Cell Survival/Death Decisions
J. Biol. Chem., March 24, 2000; 275(13): 9628 - 9635.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Le Gall, J.-C. Chambard, J.-P. Breittmayer, D. Grall, J. Pouysségur, and E. Van Obberghen-Schilling
The p42/p44 MAP Kinase Pathway Prevents Apoptosis Induced by Anchorage and Serum Removal
Mol. Biol. Cell, March 1, 2000; 11(3): 1103 - 1112.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
C. Ruiz-Ruiz, G. Robledo, J. Font, M. Izquierdo, and A. Lopez-Rivas
Protein Kinase C Inhibits CD95 (Fas/APO-1)-Mediated Apoptosis by at Least Two Different Mechanisms in Jurkat T Cells
J. Immunol., November 1, 1999; 163(9): 4737 - 4746.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. FADEEL, B. ZHIVOTOVSKY, and S. ORRENIUS
All along the watchtower: on the regulation of apoptosis regulators
FASEB J, October 1, 1999; 13(13): 1647 - 1657.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
T. H. Holmstrom, S. E. F. Tran, V. L. Johnson, N. G. Ahn, S. C. Chow, and J. E. Eriksson
Inhibition of Mitogen-Activated Kinase Signaling Sensitizes HeLa Cells to Fas Receptor-Mediated Apoptosis
Mol. Cell. Biol., September 1, 1999; 19(9): 5991 - 6002.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Scaffidi, I. Schmitz, J. Zha, S. J. Korsmeyer, P. H. Krammer, and M. E. Peter
Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells
J. Biol. Chem., August 6, 1999; 274(32): 22532 - 22538.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Whitekus, R. P. Santini, A. J. Rosenspire, and M. J. McCabe Jr.
Protection Against CD95-Mediated Apoptosis by Inorganic Mercury in Jurkat T Cells
J. Immunol., June 15, 1999; 162(12): 7162 - 7170.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Y. Liu, C. Fan, N. E. Olashaw, X. Wang, and K. S. Zuckerman
Tumor Necrosis Factor-alpha -induced Proliferation of Human Mo7e Leukemic Cells Occurs via Activation of Nuclear Factor kappa B Transcription Factor
J. Biol. Chem., May 14, 1999; 274(20): 13877 - 13885.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. WESTERMARCK and V.-M. KÄHÄRI
Regulation of matrix metalloproteinase expression in tumor invasion
FASEB J, May 1, 1999; 13(8): 781 - 792.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
W. Yu, K. Israel, Q. Y. Liao, C. M. Aldaz, B. G. Sanders, and K. Kline
Vitamin E Succinate (VES) Induces Fas Sensitivity in Human Breast Cancer Cells: Role for Mr 43,000 Fas in VES-triggered Apoptosis
Cancer Res., February 1, 1999; 59(4): 953 - 961.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. N. G. Anderson and A. M. Tolkovsky
A Role for MAPK/ERK in Sympathetic Neuron Survival: Protection against a p53-Dependent, JNK-Independent Induction of Apoptosis by Cytosine Arabinoside
J. Neurosci., January 15, 1999; 19(2): 664 - 673.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J.-H. Yeh, S.-C. Hsu, S.-H. Han, and M.-Z. Lai
Mitogen-activated Protein Kinase Kinase Antagonized Fas-associated Death Domain Protein-mediated Apoptosis by Induced FLICE-inhibitory Protein Expression
J. Exp. Med., November 16, 1998; 188(10): 1795 - 1802.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Y. Liu, C. Fan, G. Liu, N. E. Olashaw, and K. S. Zuckerman
Activation of p38 Mitogen-activated Protein Kinase Is Required for Tumor Necrosis Factor-alpha -supported Proliferation of Leukemia and Lymphoma Cell Lines
J. Biol. Chem., July 7, 2000; 275(28): 21086 - 21093.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Bertolotto, L. Maulon, N. Filippa, G. Baier, and P. Auberger
Protein Kinase C theta and epsilon Promote T-cell Survival by a Rsk-dependent Phosphorylation and Inactivation of BAD
J. Biol. Chem., November 17, 2000; 275(47): 37246 - 37250.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. F. Tran, T. H. Holmstrom, M. Ahonen, V.-M. Kahari, and J. E. Eriksson
MAPK/ERK Overrides the Apoptotic Signaling from Fas, TNF, and TRAIL Receptors
J. Biol. Chem., May 4, 2001; 276(19): 16484 - 16490.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Gomez-Angelats, C. D. Bortner, and J. A. Cidlowski
Protein Kinase C (PKC) Inhibits Fas Receptor-induced Apoptosis through Modulation of the Loss of K+ and Cell Shrinkage. A ROLE FOR PKC UPSTREAM OF CASPASES
J. Biol. Chem., June 23, 2000; 275(26): 19609 - 19619.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.